Related Experiment Video
Updated: Mar 30, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
New-onset diabetes in hypertensive patients and mortality: timing is everything
Rosa Maria Bruno1, Stefano Taddei2
1Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy Institute of Clinical Physiology, CNR, Pisa, Italy.
No abstract available in PubMed .
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
04:36Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
Published on: January 12, 2024
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Hypoglycemia and Glucagon